Published by
@ShahidNShah
@ShahidNShah
January 30 to February 1, 2024
The Colonnade Hotel, 120 Huntington Avenue, Boston, Massachusetts, 02116, United States
The rapidly evolving landscape of DDR inhibitor development sees commitment from AstraZeneca, Merck, Roche, Gilead, Artios, and IDEAYA in delivering effective cancer treatments. The 7th Annual DDR Inhibitors Summit in Boston, scheduled from 30th January 2024 at 8:30 am to 1st February 2024 at 5:00 pm, addresses the pressing need for oncology therapies. This year's conference, revamped to enhance participant experience, includes a pre-conference biomarkers focus day followed by tracks covering next-gen target discovery and clinical updates. With 150 peers in attendance, this industry-led event offers unparalleled insights into oncology innovation, synthetic lethality, and clinical development challenges.
Read on ddr-inhibitors-summit.com
Continue reading at ddr-inhibitors-summit.com
January 30 to February 1, 2024
Grand Hyatt At SFO, 55 South Mcdonnell Road, San Francisco, California, 94128, United States
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Media LLC. All Rights Reserved.
Built on May 3, 2024 at 11:31am